UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 12, 2013
Accession Number: 0001193125-13-101151
Submission Type: POS AM
CIK: 0001401923
Company Name: MAP Pharmaceuticals, Inc.
File Number: 333-157339